Coya Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.98

-0.10 (-1.97%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +640.0% upside

Low Target $27.29

Average Target $36.85

High Target $45.13

Current Price $4.98

Current
$4.98

Target
$36.85

$27.29 $36.85 avg $45.13

Scenario Analysis

Bear Case

$27.29

448.0%

Low target

Base Case

$36.85

+640.0%

Avg target

Bull Case

$45.13

+806.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.75

-35.7% from high

52-Week Low

$3.71

+34.2% from low

Target vs 52W High

$36.85

+375.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%